Ursolic acid: A promising therapeutic agent for metabolic dysfunction-associated steatotic liver disease via inhibition of SPP1-induced Th17 cell differentiation: Editorial on “Ursolic acid targets secreted phosphoprotein 1 to regulate Th17 cells against metabolic dysfunction- associated steatotic liver disease”

Saved in:
Bibliographic Details
Published in:Clinical and molecular hepatology 2024-10, Vol.30 (4), p.709
Main Authors: So Jung Kim, Jeongeun Hyun
Format: Article
Language:Korean
Subjects:
Helper T 17
Metabolic dysfunction-associated steatotic liver disease
Secreted phosphoprotein 1
Ursolic acid
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2287-2728